Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 10
1996 15
1997 15
1998 17
1999 32
2000 35
2001 53
2002 79
2003 66
2004 76
2005 86
2006 71
2007 79
2008 108
2009 131
2010 131
2011 142
2012 135
2013 150
2014 144
2015 146
2016 151
2017 118
2018 113
2019 114
2020 117
2021 123
2022 113
2023 80
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

2,443 results

Results by year

Filters applied: . Clear all
Page 1
Glatiramer acetate: A complex drug beyond biologics.
Rocco P, Eberini I, Musazzi UM, Franzè S, Minghetti P. Rocco P, et al. Eur J Pharm Sci. 2019 May 15;133:8-14. doi: 10.1016/j.ejps.2019.03.011. Epub 2019 Mar 19. Eur J Pharm Sci. 2019. PMID: 30902653 Free article. Review.
In the case of Non Biological Complex Drugs (NBCDs), complexity may arise either from the active substance, as in the case of glatiramer acetate, or from other sources, such as the formulation, as in the case of liposomes. In this paper, the case of glatiramer …
In the case of Non Biological Complex Drugs (NBCDs), complexity may arise either from the active substance, as in the case of glatiramer …
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.
Kasindi A, Fuchs DT, Koronyo Y, Rentsendorj A, Black KL, Koronyo-Hamaoui M. Kasindi A, et al. Cells. 2022 May 7;11(9):1578. doi: 10.3390/cells11091578. Cells. 2022. PMID: 35563884 Free PMC article. Review.
Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate-GA) are being examined, primarily in neurological conditions involving cognitive decline. ...
Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate-GA) are being examined, primarily in neurological co …
Glatiramer Acetate: from Bench to Bed and Back.
Arnon R, Aharoni R. Arnon R, et al. Isr Med Assoc J. 2019 Mar;21(3):151-157. Isr Med Assoc J. 2019. PMID: 30905097 Free article. Review.
Glatiramer acetate (GA, Copaxone, Copolymer1, Cop 1) is an approved drug for the treatment of relapsing-remitting multiple sclerosis (RRMS). ...
Glatiramer acetate (GA, Copaxone, Copolymer1, Cop 1) is an approved drug for the treatment of relapsing-remitting multiple scl …
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
McKeage K. McKeage K. CNS Drugs. 2015 May;29(5):425-32. doi: 10.1007/s40263-015-0245-z. CNS Drugs. 2015. PMID: 25906331 Review.
Glatiramer acetate (Copaxone()) is a synthetic analogue of myelin basic protein, which is thought to be involved in the pathogenesis of multiple sclerosis (MS). ...Recently, a high-concentration formulation of glatiramer acetate 40 mg/mL administered t …
Glatiramer acetate (Copaxone()) is a synthetic analogue of myelin basic protein, which is thought to be involved in the pathog …
The Evolving Mechanisms of Action of Glatiramer Acetate.
Prod'homme T, Zamvil SS. Prod'homme T, et al. Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):a029249. doi: 10.1101/cshperspect.a029249. Cold Spring Harb Perspect Med. 2019. PMID: 29440323 Free PMC article. Review.
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS). ...
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple scl …
Glatiramer acetate for multiple sclerosis.
La Mantia L, Munari LM, Lovati R. La Mantia L, et al. Cochrane Database Syst Rev. 2010 May 12;(5):CD004678. doi: 10.1002/14651858.CD004678.pub2. Cochrane Database Syst Rev. 2010. PMID: 20464733 Review.
OBJECTIVES: To verify the clinical efficacy of glatiramer acetate in the treatment of MS patients with relapsing remitting (RR) and progressive (P) course. ...Local injection-site reactions were observed in up to a half of patients treated with glatiramer …
OBJECTIVES: To verify the clinical efficacy of glatiramer acetate in the treatment of MS patients with relapsing remitting (RR …
Multiple Sclerosis.
Reich DS, Lucchinetti CF, Calabresi PA. Reich DS, et al. N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483. N Engl J Med. 2018. PMID: 29320652 Free PMC article. Review. No abstract available.
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.
Boster AL, Ford CC, Neudorfer O, Gilgun-Sherki Y. Boster AL, et al. Expert Rev Neurother. 2015 Jun;15(6):575-86. doi: 10.1586/14737175.2015.1040768. Epub 2015 Apr 30. Expert Rev Neurother. 2015. PMID: 25924547 Review.
Glatiramer acetate (GA) is approved for relapsing-remitting multiple sclerosis in 57 countries worldwide, with more than 2 million patient-years of exposure and over 20 years of continuous clinical use without new safety concerns. ...
Glatiramer acetate (GA) is approved for relapsing-remitting multiple sclerosis in 57 countries worldwide, with more than 2 mil …
Aseptic meningitis after glatiramer acetate.
Niessen A, Schwarz B, Urban M, Krämer S, Reinhard M. Niessen A, et al. J Neurol. 2021 Jul;268(7):2589-2590. doi: 10.1007/s00415-021-10572-z. Epub 2021 Apr 28. J Neurol. 2021. PMID: 33909159 No abstract available.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Fragoso YD. Fragoso YD. Expert Opin Drug Saf. 2014 Dec;13(12):1743-8. doi: 10.1517/14740338.2014.955849. Epub 2014 Sep 1. Expert Opin Drug Saf. 2014. PMID: 25176273 Review.
AREAS COVERED: This paper reviews the literature on pregnancies where the mother was exposed to glatiramer acetate . Few data are available on paternal exposure, but this does not seem to pose a problem due to the pharmacological characteristics of the drug. ...EXPE …
AREAS COVERED: This paper reviews the literature on pregnancies where the mother was exposed to glatiramer acetate . Few data …
2,443 results

Searches related to "glatiramer acetate"